Antonello Veccia

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone

Cristian Lolli, Orazio Caffo, Emanuela Scarpi et al. · Frontiers in Pharmacology · 2016 · 198 citations · Full text

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study

Orazio Caffo, Ugo De Giorgi, Lucia Fratino et al. · European Urology · 2014 · 83 citations · Full text

Italian Multicentre Study, Urology, Genitourinary Cancer +9

Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial

Maria Carmela Piccirillo, Laura Bonanno, Marina Chiara Garassino et al. · Journal of Thoracic Oncology · 2022 · 63 citations · Full text

Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations

Silvia Casagrande, Giulia Boscato Sopetto, Giovanni Bertalot et al. · Cancers · 2024 · 60 citations · Full text

Immunology, Immune Regulation, Pathology +25

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi et al. · Journal of Hepatology · 2023 · 56 citations · Full text